Scarica l'app Stockscreener
44.98
0.60%
0.27
Pre-mercato:
44.91
-0.07
-0.16%
Precedente Chiudi:
$44.71
Aprire:
$44.44
Volume 24 ore:
338.57K
Relative Volume:
0.75
Capitalizzazione di mercato:
$3.41B
Reddito:
$597.97M
Utile/perdita netta:
$35.92M
Rapporto P/E:
100.33
EPS:
0.4483
Flusso di cassa netto:
$101.73M
1 W Prestazione:
+3.35%
1M Prestazione:
+5.41%
6M Prestazione:
+37.39%
1 anno Prestazione:
+128.32%
Intervallo 1D:
$43.11
$44.98
Intervallo di 1 settimana:
$41.98
$45.01
Portata 52W:
$18.25
$45.50
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile
Nome
Kiniksa Pharmaceuticals International Plc
Settore
Telefono
(781) 431-9100
Indirizzo
23 OLD BOND STREET, FLOOR 3, LONDON
Compare KNSA vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KNSA
Kiniksa Pharmaceuticals International Plc
|
44.98 | 3.39B | 597.97M | 35.92M | 101.73M | 0.4483 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-29 | Iniziato | TD Cowen | Buy |
| 2025-03-13 | Iniziato | Citigroup | Buy |
| 2024-09-13 | Iniziato | Jefferies | Buy |
| 2024-05-03 | Iniziato | Wells Fargo | Overweight |
| 2020-06-29 | Reiterato | BofA Securities | Buy |
| 2020-04-01 | Iniziato | BofA/Merrill | Buy |
| 2019-03-11 | Iniziato | Barclays | Overweight |
| 2018-12-12 | Reiterato | Wedbush | Outperform |
| 2018-06-19 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Kiniksa Pharmaceuticals International Plc Borsa (KNSA) Ultime notizie
Mark Ragosa Sells 17,845 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat
Kiniksa Pharmaceuticals International, plc $KNSA Shares Purchased by Essex Investment Management Co. LLC - MarketBeat
Y Intercept Hong Kong Ltd Has $248,000 Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Director Sells 830 Shares of Stock - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Director Sells 2,602 Shares - MarketBeat
Barry Quart Sells 12,528 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat
Kiniksa Pharmaceuticals Interna (KNSA) Stock Analysis: 23% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Hits New 52-Week HighHere's What Happened - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Acquires 51,204 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Combines High Growth Momentum with Strong Technical Setup - Chartmill
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 12-Month HighTime to Buy? - MarketBeat
Kiniksa: Arcalyst Is The Engine, But KPL-387 Is The Accelerator - Seeking Alpha
Kiniksa Pharmaceuticals International, Plc's (NASDAQ:KNSA) Revenues Are Not Doing Enough For Some Investors - 富途资讯
Risk Off: Can Kiniksa Pharmaceuticals Ltd reach all time highs this yearQuarterly Profit Summary & Consistent Income Trade Ideas - baoquankhu1.vn
Kiniksa issues updates on abiprubart, KPL-387, mavrilimumab - MSN
Campbell & CO Investment Adviser LLC Makes New $1.48 Million Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
First Week of March 20th Options Trading For Kiniksa Pharmaceuticals International (KNSA) - Nasdaq
Kiniksa Pharmaceuticals International PLC (KNSA) Trading Down 4. - GuruFocus
Kiniksa Pharmaceuticals International (KNSA) Is Down 6.7% After Raising 2026 ARCALYST Revenue OutlookHas The Bull Case Changed? - simplywall.st
Kiniksa Pharmaceuticals appoints new chief operating and strategy officers By Investing.com - Investing.com South Africa
Kiniksa Pharmaceuticals appoints new chief operating and strategy officers - Investing.com
Kiniksa Pharmaceuticals Reshapes Leadership With New COO, CSO - TipRanks
Kiniksa Pharmaceuticals International, plc Appoints Management Team, Effective January 10, 2026 - marketscreener.com
Wedbush Issues Positive Forecast for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price - Defense World
Wedbush Raises Price Target for Kiniksa Pharmaceuticals (KNSA) | - GuruFocus
KNSA stock slides 6% after Kiniksa maps out $900–$920 million ARCALYST outlook — what’s next - TechStock²
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Trading Down 5.6%Time to Sell? - MarketBeat
High Growth US Tech Stocks To Watch In January 2026 - simplywall.st
Kiniksa Pharmaceuticals International PLC (KNSA) Stock Price Dow - GuruFocus
Kiniksa reports 62% growth in ARCALYST revenue, forecasts 2026 sales By Investing.com - Investing.com Nigeria
Kiniksa Pharmaceuticals Provides Corporate Update - TradingView — Track All Markets
Kiniksa reports 62% growth in ARCALYST revenue, forecasts 2026 sales - Investing.com
Mark Ragosa Sells 12,000 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - Defense World
Kiniksa Pharmaceuticals International, plc $KNSA Stock Holdings Reduced by Peregrine Capital Management LLC - MarketBeat
Insider Sell: Mark Ragosa Sells 12,000 Shares of Kiniksa Pharmac - GuruFocus
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CFO Sells $502,680.00 in Stock - MarketBeat
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference - Sahm
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price Down 6.2%Here's What Happened - MarketBeat
Kiniksa Pharmaceuticals International, plc $KNSA Shares Sold by Voya Investment Management LLC - Defense World
Rice Hall James & Associates LLC Reduces Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Why Analysts Favor Kiniksa Pharmaceuticals (KNSA) - Finviz
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 12-Month High – Time to Buy? - Defense World
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 52-Week HighTime to Buy? - MarketBeat
Barry Quart Sells 20,129 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - Defense World
Kiniksa Pharmaceuticals International Plc Azioni (KNSA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.21%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):